UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 5, 2023

Accession Number:	0001193125-23-070227
Submission Type:	POS AM
CIK: 0001645666 Company Name: Kezar Life Sciences, Inc. File Number: 333-261774